![](/img/cover-not-exists.png)
Remission maintenance after tocilizumab dose-tapering and interruption in patients with giant cell arteritis: an open-label, 18-month, prospective, pilot study
Nannini, Carlotta, Niccoli, Laura, Sestini, Stelvio, Laghai, Iashar, Coppola, Angela, Cantini, FabrizioJournal:
Annals of the Rheumatic Diseases
DOI:
10.1136/annrheumdis-2019-215585
Date:
June, 2019
File:
PDF, 178 KB
2019